Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Kargbo

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
ACS Medicinal Chemistry Letters|March 19, 2021
Degradation of Janus Kinase for Potential Application in Immune Response TherapeuticsRobert B Kargbo
ACS Medicinal Chemistry Letters|March 19, 2021
Androgen Receptor Protein Degradation in the Treatment of Castration-Resistant Prostate CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2021
Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2021
5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|January 25, 2021
Degradation of Signal Transducer and Activator of Transcription Proteins in Cancer TherapeuticsRobert B Kargbo
ACS Medicinal Chemistry Letters|March 21, 2019
PROTAC Molecules for the Treatment of Autoimmune DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|October 18, 2019
PROTAC-Mediated Degradation of Estrogen Receptor in the Treatment of CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|April 22, 2022
Selective Serotonin Receptor Modulators for Use in the Treatment of Psychological DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|October 22, 2021
Protein Degradation Inducers of Androgen Receptor by Conjugation of Antagonists Androgen Receptor and E3 Ligase LigandRobert B Kargbo
ACS Medicinal Chemistry Letters|October 22, 2021
Psychedelic Therapeutic: Potential Treatment for Headache DisordersRobert B Kargbo
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
ACS Medicinal Chemistry Letters|March 19, 2021
Degradation of Janus Kinase for Potential Application in Immune Response TherapeuticsRobert B Kargbo
ACS Medicinal Chemistry Letters|March 19, 2021
Androgen Receptor Protein Degradation in the Treatment of Castration-Resistant Prostate CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2021
Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2021
5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|January 25, 2021
Degradation of Signal Transducer and Activator of Transcription Proteins in Cancer TherapeuticsRobert B Kargbo
ACS Medicinal Chemistry Letters|March 21, 2019
PROTAC Molecules for the Treatment of Autoimmune DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|October 18, 2019
PROTAC-Mediated Degradation of Estrogen Receptor in the Treatment of CancerRobert B Kargbo
ACS Medicinal Chemistry Letters|April 22, 2022
Selective Serotonin Receptor Modulators for Use in the Treatment of Psychological DisordersRobert B Kargbo
ACS Medicinal Chemistry Letters|October 22, 2021
Protein Degradation Inducers of Androgen Receptor by Conjugation of Antagonists Androgen Receptor and E3 Ligase LigandRobert B Kargbo
ACS Medicinal Chemistry Letters|October 22, 2021
Psychedelic Therapeutic: Potential Treatment for Headache DisordersRobert B Kargbo
Pageof 26